Medtronic

After a five-year pilot, only one company has successfully taken a test through parallel review, but there is growing industry interest.

Gathering the Data

IBM and its partners look to combine health information to develop a health platform for the Watson supercomputer.

Title: Methods for Diagnosing Prostate Cancer using microRNAs
Patent Number: 8,557,520
Filed: Feb. 28, 2012
Lead Inventor: Carlo Croce, Ohio State University

NEW YORK (GenomeWeb News) – In a sort of test case for personalized medicine, a team of clinicians and researchers used whole-genome sequencing to uncover variants possibly linked to a patient's obsessive-compulsive disorder.

Response Genetics, Taiho Extend MDx Services Pact
Response Genetics could receive up to $950,000 for molecular diagnostic testing services provided to Taiho Pharmaceutical related to the development of cancer treatments.

Dutch gene therapy firm UniQure and academic collaborators have been awarded a three-year grant worth €2.5 million ($3.2 million) from the European Commission to develop a treatment for Huntington’s disease that combines RNAi and gene replacement.

Title: Expression System
Patent Number: 8,415,148
Filed: Aug. 2, 2011
Inventor: Jacques Perrault, San Diego State University

Title: Method for Diagnosing Acute Lymphomic Leukemia using miR-222
Patent Number: 8,349,560
Filed: Oct. 17, 2011
Inventor: Carlo Croce, Ohio State University

Title: miRNA Triplex Formations for the Down-Regulation of Viral Replication
Patent Number: 8,323,891
Filed: July 30, 2009
Inventor: Omar Bagasra, Claflin University

Title: shRNA Molecules and Methods of Use
Patent Number: 8,252,526
Filed: Nov. 9, 2007
Lead Inventor: Donald Rao, Gradalis

Pages

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.